MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-15-2023
Lannett Company Total Inventories 2011-2025 | LCI
Annual Total Inventories Lannett Company
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 95.2 M | 110 M | 143 M | 144 M | 142 M | 123 M | 115 M | 46.2 M | 44.8 M | 32.5 M | 27.1 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 144 M | 27.1 M | 92.8 M |
Quarterly Total Inventories Lannett Company
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90.8 M | 94.8 M | 94.1 M | 95.2 M | 95.4 M | 106 M | 113 M | 110 M | 110 M | 122 M | 156 M | 143 M | 143 M | 152 M | 149 M | 144 M | 144 M | 136 M | 146 M | 142 M | 142 M | 136 M | 125 M | 123 M | 123 M | 130 M | 128 M | 115 M | 115 M | 124 M | 45.2 M | 46.2 M | 46.2 M | 42.6 M | 44.1 M | 44.8 M | 44.8 M | 35.8 M | 34.5 M | 32.5 M | 32.5 M | 30.7 M | 27.6 M | 27.1 M | 27.1 M | 23.9 M | 26.5 M | 26.9 M | 26.9 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 156 M | 23.9 M | 90 M |
Total Inventories of other stocks in the Drug manufacturers industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
1.88 M | - | - | $ 142 M |  USA |
 |
Assertio Holdings
ASRT
|
37.7 M | $ 0.73 | -3.6 % | $ 51.9 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
40.4 M | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
96.4 M | $ 1.7 | -2.59 % | $ 183 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
1.11 M | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
1.24 M | - | 0.86 % | $ 117 M | USA |
 |
Agile Therapeutics
AGRX
|
2.74 M | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
574 M | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
2.22 M | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
47.8 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
246 M | - | - | $ 28.9 M |  Irlanda |
 |
Emergent BioSolutions
EBS
|
329 M | $ 12.37 | 8.32 % | $ 633 M | USA |
 |
Evoke Pharma
EVOK
|
482 K | $ 10.96 | 0.09 % | $ 36.6 M | USA |
 |
Athenex
ATNX
|
42.7 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
20.3 M | $ 21.43 | 0.3 % | $ 2.04 B |  France |
 |
Evolus
EOLS
|
12.2 M | $ 7.18 | 1.99 % | $ 445 M | USA |
 |
Harrow Health
HROW
|
10.9 M | $ 46.29 | -1.64 % | $ 1.51 B | USA |
 |
China Pharma Holdings
CPHI
|
2.27 M | $ 1.53 | -1.92 % | $ 26.7 M |  China |
 |
Bausch Health Companies
BHC
|
1.54 B | $ 6.9 | -0.36 % | $ 2.52 B | Canada |
 |
Organogenesis Holdings
ORGO
|
26.2 M | $ 4.78 | -0.83 % | $ 629 M | USA |
 |
Pacira BioSciences
PCRX
|
125 M | $ 26.61 | 1.22 % | $ 1.23 B | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
4 M | $ 3.11 | 22.92 % | $ 43.7 M | USA |
 |
Rockwell Medical
RMTI
|
5.87 M | $ 0.88 | -5.3 % | $ 20.5 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
2.92 M | $ 3.55 | -1.11 % | $ 4.41 M | USA |
 |
PetIQ
PETQ
|
159 M | - | 1.64 % | $ 400 M | USA |
 |
Jupiter Wellness
JUPW
|
234 K | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
1.08 B | $ 12.77 | -2.78 % | $ 1.75 B | USA |
 |
ProPhase Labs
PRPH
|
3.98 M | $ 0.11 | -0.35 % | $ 1.74 M | USA |
 |
Radius Health
RDUS
|
11.4 M | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
10.3 M | - | -4.76 % | $ 65.3 M | USA |
 |
Veru
VERU
|
4.14 M | $ 2.4 | -0.83 % | $ 324 M | USA |
 |
OptiNose
OPTN
|
8.05 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
2.46 M | - | -27.8 % | $ 2.56 M | USA |
 |
cbdMD
YCBD
|
2.52 M | $ 1.19 | -0.83 % | $ 5.13 M | USA |
 |
SCYNEXIS
SCYX
|
899 K | $ 0.64 | -0.91 % | $ 30.6 M | USA |
 |
Tilray
TLRY
|
201 M | $ 11.01 | -9.4 % | $ 6.8 B | Canada |
 |
TherapeuticsMD
TXMD
|
7.99 M | $ 1.7 | -2.86 % | $ 17.7 M | USA |
 |
Zomedica Corp.
ZOM
|
5.12 M | - | -0.21 % | $ 98 M | USA |
 |
Viatris
VTRS
|
3.52 B | $ 11.68 | 0.29 % | $ 14.2 B | USA |